Chiesi the Netherlands was established in 2007. We have since grown to become a reputable player in the Dutch pharmaceutical industry. This evolution is driven by three key factors: the introduction of innovative medicines from our own pipeline, the development of existing medicines, and a successful acquisition and licensing strategy. Chiesi the Netherlands has an extensive product portfolio and focuses on six areas: asthma, COPD, CF, neonatology, transplantation and rare diseases. Our entrepreneurial and flexible approach is a key success factor for Chiesi the Netherlands and is highly valued by our customers.
Number of employees:
Number of active countries: 1
Our comprehensive independent research revealed that Chiesi Pharmaceuticals B.V. provides exceptional employee conditions, nurtures and develops talent throughout all levels of the organisation and has demonstrated its leadership status in the HR environment, always striving to optimise its employment practices and to develop its employees.
We help your organisation adapt to the rapidly changing HR environmentHow we certify